Again within 6 months they have a revolutionary drug that’s a completely new molecule the first of its kind that functions how it’s supposed to both pre clinically and in humans, safe in humans for both traumatic brain injury and stroke and fully funded
2 million market cap, lights off lol. Hawk70 your a genius keep posting. Just like AGN north of a 100 million market cap is where this sits. North of a billion dollars on phase 2 completion. Just like AGN about to sell 50 percent of its drug for 500 million dollars coming up. But apparently NYR are going to a 2 million market cap and de listing hahahah MSB a $20 dollar stock (30 billion market cap) on FDA approval that makes me laugh every time
NYR Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
